Sydney Health Ethics: Recent submissions
-
Finally, unproven stem cell clinic practices might be curtailed
Published 2017-10-27In a welcomed move, the Therapeutic Goods Administration (TGA) has this week announced reforms will be introduced in 2018 to address long held concerns about the provision of unproven stem cell treatments to increasing ...Open AccessArticle -
Genetics and insurance in Australia: Concerns around a self-regulated industry
Published 2017-10-26Background: Regulating the use of genetic information in insurance is an issue of ongoing international debate. In Australia, providers of life and other mutually rated insurance products can request applicants to disclose ...Open AccessArticle -
Gene editing advance re‐ignites debate on the merits and risks of animal to human transplantation
Published 2016-01-01In Australia and internationally, the shortage of organ and tissue donors significantly limits the number of patients with critical organ or tissue failure who are able to receive a transplant each year. The rationale for ...Open AccessArticle -
Coverage with evidence development and managed entry in the funding of personalized medicine: practical and ethical challenges for oncology
Published 2015-01-01Personalized medicines hold promise for many diseases. However, demonstrating the clinical efficacy and cost effectiveness of these medicines can be difficult. It is essential that decisionmaking processes for funding new ...Open AccessArticle -
Demands for access to new therapies: are there alternatives to accelerated access?
Published 2017-10-02Patients deserve timely access to new therapies, but the rhetoric surrounding accelerated access impedes rational policy making.It is almost impossible to turn on the television or open a newspaper without hearing about ...Open AccessArticle